RheumaGen
0 followers
‌
RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.
Industries
Headquarters
Employees
Links
Org chart
Richard Freed
Chief Executive Officer
Richard Freed
Collapse
Similar companies
Thermo Fisher Scientific
149 followers
Alexion Pharmaceuticals
33 followers
SpringWorks Therapeutics
4 followers
Quantum-Si
2 followers
Recursion Pharmaceuticals
6 followers
SOPHiA GENETICS
4 followers
Amgen
187 followers
Sana Biotechnology
1 follower
TGen
1 follower
Applied StemCell
1 follower
ShareBaby
4 followers
Discover companies